EMA is not yet established in Amsterdam or pharma companies are already in line to come to Amsterdam
September 22, 2018The first effects of the arrival of the European Medicines Agency EMA are already being felt.
The EMA effect is also good news for scientific research. Director Bart Klijsen of IXA VU-VUmc says, “In order to bring research to society, cooperation and participation with companies is indispensable. This requires a mature ecosystem. That is why the arrival of EMA is positive for the Netherlands and for the region. Although not all contacts are directly related to EMA, there is a lot more interest from the medical industry in Amsterdam.”
Read the full Parool article of Herman Stil, Artikel-Parool-Als-EMA-over-de-dam-is…..pdf
More news
KTO Masterclass in CES Unveiled at Beurs van Berlage
On the 17th of October, 70 KTO colleagues from the different universities of the Netherlands came together to participate in the annual KTO Masterclass as part of CES Unveiled at the Beurs van Berlage, hosted by IXA. Gigi Wang kicked of the day with an energizing presentation. Gigi runs the MG-Team, which delivers global entrepreneurship […]
News
EU-rapport: HvA is voorbeeld in ondernemerschaps-onderwijs
Nederland loopt voorop in het integreren van ondernemerschap en innovatie in het hoger onderwijs ten opzichte van andere Europese landen. Dat blijkt uit een rapport dat in opdracht van de OESO tot stand kwam. De HvA wordt als voorbeeld genoemd voor andere instellingen. Supporting Entrepreneurship and Innovation in Higher Education in the Netherlands werd gepubliceerd […]
News
Nico.lab to Australian stock exchange and North America
The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the […]
News